Status:

COMPLETED

Training Data Collection & AI Development

Lead Sponsor:

Aristotle University Of Thessaloniki

Collaborating Sponsors:

Region Stockholm

Conditions:

Breast Cancer

Prostate Cancer

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

The aim of this study is to facilitate collection of real-world data to test and train the analytics engine for each prototype algorithm. Preliminary datasets will be generated to enable a dry run of ...

Detailed Description

"The LifeChamps project (https://lifechamps.eu/) is creating a digital platform to support clinical teams to provide more integrated follow-up care to older patients with cancer. The digital platform ...

Eligibility Criteria

Inclusion

  • Breast or prostate cancer.
  • Diagnosed with early stage (I-III) cancer (breast, prostate) and living beyond initial cancer treatment (curative/incurable).
  • Diagnosed with advanced or metastatic disease with life expectancy \>12 months.
  • At least 1 month after a) local treatment with curative intent (surgery, radiotherapy) or b) initiation of systemic treatment (hormone treatment, CDK4/6 or new generation antiandrogens).
  • Absence of diagnosed secondary malignancy.
  • Deemed by a member of the multidisciplinary team as physically and psychologically fit to participate in the study.
  • Able to read, write and understand the respective local language (greek).
  • Achieve a score of above 2 on the Mini-Cog during the screening process.
  • Able to bring and use own Android version 10 (or above) device during the study.
  • Domestic 24/7 internet access via wi-fi and/or 4G mobile data (will be provided if unavailable).

Exclusion

  • Currently receiving chemotherapy.
  • Terminal cancer stage on palliative care.
  • Survival prognosis of \<18 months from the time of recruitment.
  • Unwilling to provide written informed consent.
  • Presence of internal medical device (e.g. pacemaker etc.)

Key Trial Info

Start Date :

July 31 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 10 2023

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT05378854

Start Date

July 31 2022

End Date

April 10 2023

Last Update

May 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Laboratory of Medical Physics and Digital Innovation, AUTH

Thessaloniki, Greece, 54636